Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

ABSTRACT: The purpose of this clinical research is to establish a multi-omics model based on genomics，transcriptomics，gut microbiota in predicting pathologic response after neoadjuvant chemoradiotherapy combined PD-1 antibody given to patients with locally advanced rectal cancer.

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2729715 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR